These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15628718)

  • 1. Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?
    Poelmans J; Tack J; Feenstra L
    Dig Dis Sci; 2004; 49(11-12):1868-74. PubMed ID: 15628718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal laryngospasm secondary to gastroesophageal reflux.
    Loughlin CJ; Koufman JA
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1502-5. PubMed ID: 8948611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngospasm: an atypical manifestation of severe gastroesophageal reflux disease (GERD).
    Maceri DR; Zim S
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1976-9. PubMed ID: 11801981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of long-term outcome of patients with reflux-related ear, nose, and throat symptoms.
    Poelmans J; Feenstra L; Tack J
    Dig Dis Sci; 2006 Feb; 51(2):282-8. PubMed ID: 16534670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy.
    Poelmans J; Tack J; Feenstra L
    Ann Otol Rhinol Laryngol; 2002 Oct; 111(10):933-8. PubMed ID: 12389864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.
    Sandur V; Murugesh M; Banait V; Rathi PM; Bhatia SJ; Joshi JM; Kate A
    J Postgrad Med; 2014; 60(3):282-6. PubMed ID: 25121368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of medical therapy and antireflux surgery on dysphagia in patients with gastroesophageal reflux disease without esophageal stricture.
    Wetscher GJ; Glaser K; Gadenstaetter M; Profanter C; Hinder RA
    Am J Surg; 1999 Mar; 177(3):189-92. PubMed ID: 10219852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
    Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
    Poe RH; Kallay MC
    Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.
    Nelson WW; Vermeulen LC; Geurkink EA; Ehlert DA; Reichelderfer M
    Arch Intern Med; 2000 Sep; 160(16):2491-6. PubMed ID: 10979061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J; Dodd S; Durkin M; Sloan S
    Manag Care; 2002 Jul; 11(7 Suppl):14-8. PubMed ID: 12181872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
    Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
    Freston JW
    Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of (duodeno)gastroesophagopharyngeal reflux in unexplained excessive throat phlegm.
    Poelmans J; Feenstra L; Tack J
    Dig Dis Sci; 2005 May; 50(5):824-32. PubMed ID: 15906752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laryngeal manifestations of gastroesophageal reflux disease (GERD) in pediatric patients: the usefulness of therapeutic (proton pump inhibitor (PPI)) trials].
    Saigusa H; Niimi S; Saigusa U; Yagi T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Oct; 104(10):1025-33. PubMed ID: 11710151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?
    Juul-Hansen P; Rydning A
    Scand J Gastroenterol; 2003 Dec; 38(12):1200-3. PubMed ID: 14750637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.